Drug shortage
Tiagabine Hydrochloride Tablet · Teva Pharmaceuticals USA, Inc.
FDA drug shortage · To Be Discontinued · updated Apr 15, 2026
Key facts
| Generic name | Tiagabine Hydrochloride Tablet |
|---|---|
| Company | Teva Pharmaceuticals USA, Inc. |
| Presentation | Tiagabine Hydrochloride, Tablet, 4mg 30 count (NDC 0093-5031-56) |
| Dosage form | Tablet |
| Status | To Be Discontinued |
| Therapeutic category | Neurology |
| Package NDCs | 0093-5031-56 |
| First posted | Apr 15, 2026 |
| Last updated | Apr 15, 2026 |
| Discontinued | Apr 15, 2026 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: